←
Maximilian Strobl435 posts
Maximilian Strobl avatar

Maximilian Strobl

@StroblMAR

Eric and Wendy Schmidt AI in Science Postdoctoral Fellow. Combining ecology, evolution and mathematics to improve cancer treatment scheduling.

◷ Joined November 2016▧ 96 Photos and videos
Maximilian Strobl avatar
Maximilian Strobl@StroblMAR·1 Aug 2025

Idea 2: low dose targeted therapy combos, optimized via math models, to provide options for those patients who are not eligible for PARPis.

Post attachment
Maximilian Strobl avatar
Maximilian Strobl@StroblMAR·1 Aug 2025

Idea 1: Better toxicity monitoring systems using AI and new fluctuating methylation clocks to assess bone marrow health.

Post attachment
Maximilian Strobl avatar
Maximilian Strobl@StroblMAR·1 Aug 2025

Evolutionary theory tells us that to cure #ovariancancer we need to target it when its most vulnerable – at the end of 1st-line tx. The challenge: that’s also when treatment-induced toxicity is greatest. Check out our new @imoworkshop pre-print with 3 ideas how to tackle this!

Post attachment
Maximilian Strobl avatar
Maximilian Strobl@StroblMAR·10 Nov 2024

Very proud of this team snatching up 1st place & $50k pilot funding towards beating HR+ #ovariancancer at @imoworkshop. It was my 1st time as team lead and more than anything it was simply a lot of fun! Thanks #TeamRuby for an incredible week! Looking forward to what's next!

The winners of the 12th @imoworkshop on Toxicity are #TeamRed! Led by the synergistic combination of @ErinGeorgeMD @StroblMAR & Paulo Rodriguez. Congratulations on a unanimous win!! Excited to see where this project goes with the $50K winning prize from @MoffittNews #MoffittIMO

Post attachment
Maximilian Strobl avatar
Maximilian Strobl@StroblMAR·24 Jul 2024

Thanks for the shoutout! I fully agree. Models help us to better design and interpret our experiments and conversely experiments enable us to calibrate and advance our models. In short: Integration drives iteration drives progress!

#SysBio4CancerResearch: The best way to bring preclinical data to bear on clinical translation is the integration of mathematical models to interpolate or extrapolate these data, and to test & generate hypotheses about underlying biological mechanisms. A recent great example of model iteration is @stroblmar’s paper on PARP inhibitors in ovarian cancer: cell.com/cell-systems/abstra…

Post attachment
Jeffrey West avatar
⟳ Maximilian Strobl retweeted
Jeffrey West@mathoncbro·24 Jul 2024

#SysBio4CancerResearch: The best way to bring preclinical data to bear on clinical translation is the integration of mathematical models to interpolate or extrapolate these data, and to test & generate hypotheses about underlying biological mechanisms. A recent great example of model iteration is @stroblmar’s paper on PARP inhibitors in ovarian cancer: cell.com/cell-systems/abstra…

Post attachment
Jeff Maltas avatar
⟳ Maximilian Strobl retweeted
Jeff Maltas@JeffMaltas·9 Jul 2024

Our recent @PRX_Life paper was selected as the very first journal cover and it looks great :) Past thread explaining why we're are just so excited about this result below:

Post attachment

Incredibly excited that our paper examining the role of ecological interactions in preexisting drug resistance is out! We tackle the apparent paradox between the cost of resistance in the absence of treatment, and the ubiquity of preexistence. 1/20 Link: go.aps.org/4c5FmH4

Post attachment